Morpholines Concept

subject area of

• A Phase I Evaluation of Oral CI-1033 in Combination with Paclitaxel and Carboplatin as First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer  Journal Articles
• A Replacement for Warfarin  Journal Articles
• A logical approach to surgical thromboprophylaxis  Journal Articles
• A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment  Journal Articles
• Acute management of bleeding in patients on novel oral anticoagulants  Journal Articles
• Advances in the management of venous thromboembolism  Journal Articles
• Advances in the management of venous thromboembolism.  Journal Articles
• Advantages and limitations of the new anticoagulants  Journal Articles
• After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding  Journal Articles
• An Open Trial of Reboxetine in HIV-Seropositive Outpatients With Major Depressive Disorder  Journal Articles
• An open trial of reboxetine in obese patients with binge eating disorder  Journal Articles
• Anti-pneumococcal deficits of monocyte-derived macrophages from the advanced-age, frail elderly and related impairments in PI3K-AKT signaling  Journal Articles
• Approach to the new oral anticoagulants in family practice: part 1: comparing the options.  Journal Articles
• Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions.  Journal Articles
• Assays for Measuring Rivaroxaban: Their Suitability and Limitations  Journal Articles
• BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study  Journal Articles
• Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach  Journal Articles
• Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty  Journal Articles
• Beyond Unfractionated Heparin and Warfarin  Journal Articles
• Bleeding and antidotes in new oral anticoagulants  Journal Articles
• Cannabinoid WIN55212‐2 impairs peanut‐allergic sensitization and promotes the generation of allergen‐specific regulatory T cells  Journal Articles
• Characterization of Mutational Status, Spheroid Formation, and Drug Response of a New Genomically-Stable Human Ovarian Clear Cell Carcinoma Cell Line, 105C  Journal Articles
• Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications  Journal Articles
• Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development  Journal Articles
• Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?  Journal Articles
• Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated partial thromboplastin times using various reagents  Journal Articles
• Comparison of three‐factor and four‐factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers  Journal Articles
• Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation  Journal Articles
• Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada  Journal Articles
• Design of the rivaroxaban for heparin-induced thrombocytopenia study  Journal Articles
• Developmental effects of the industrial cooling water additives morpholine and sodium hypochlorite on lake whitefish (Coregonus clupeaformis)  Journal Articles
• Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials  Journal Articles
• Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials.  Journal Articles
• Effectin vitroon platelet function of two compounds developed from the pyrimido-pyrimidines  Journal Articles
• Enoxaparin Versus Dabigatran or Rivaroxaban for Thromboprophylaxis After Hip or Knee Arthroplasty  Journal Articles
• Evolving use of new oral anticoagulants for treatment of venous thromboembolism  Journal Articles
• Factor Xa and thrombin as targets for new oral anticoagulants  Journal Articles
• Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials  Journal Articles
• Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open‐label study  Journal Articles
• Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies  Journal Articles
• Genome-based taxonomic framework for the class Negativicutes: division of the class Negativicutes into the orders Selenomonadales emend., Acidaminococcales ord. nov. and Veillonellales ord. nov.  Journal Articles
• Guanosine Protects Glial Cells Against 6-Hydroxydopamine Toxicity  Journal Articles
• Guanosine protects SH-SY5Y cells against β-amyloid-induced apoptosis  Journal Articles
• How I treat target-specific oral anticoagulant–associated bleeding  Journal Articles
• Impacts of temperature, morpholine, and chronic radiation on the embryonic development of round whitefish (Prosopium cylindraceum)  Journal Articles
• Insulin increases FA uptake and esterification but reduces lipid utilization in isolated contracting muscle  Journal Articles
• Interleukins 4 and 13 Increase Intestinal Epithelial Permeability by a Phosphatidylinositol 3-Kinase Pathway  Journal Articles
• Ionizing Radiation Activates AMP-Activated Kinase (AMPK): A Target for Radiosensitization of Human Cancer Cells  Journal Articles
• Is there a role for the novel oral anticoagulants in patients with an acute coronary syndrome? A review of the clinical trials  Journal Articles
• Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants  Journal Articles
• Landiolol for perioperative atrial tachyarrhythmias in cardiac and thoracic surgery patients: a systematic review and meta-analysis  Journal Articles
• Landiolol for the prevention of postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis  Journal Articles
• Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program  Journal Articles
• Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor  Journal Articles
• Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting  Journal Articles
• Micronuclei formation in rainbow trout cells exposed to multiple stressors: Morpholine, heat shock, and ionizing radiation  Journal Articles
• Monitoring the anticoagulant effect after a massive rivaroxaban overdose  Journal Articles
• Multicenter, Randomized Phase II Trial of Oral CI-1033 for Previously Treated Advanced Ovarian Cancer  Journal Articles
• New Anticoagulants for Atrial Fibrillation  Journal Articles
• New Anticoagulants for Treatment of Venous Thromboembolism  Journal Articles
• New Anticoagulants for the Prevention of Thromboembolism  Journal Articles
• New Antithrombotic Drugs: Potential for Use in Oncology  Journal Articles
• New oral anticoagulant agents – general features and outcomes in subsets of patients  Journal Articles
• New oral anticoagulants and oculoplastic surgery  Journal Articles
• New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions  Journal Articles
• New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplasty  Journal Articles
• New oral anticoagulants in elderly patients  Journal Articles
• New oral anticoagulants: not quite there yet  Journal Articles
• New oral anticoagulants: which one should my patient use?  Journal Articles
• Novel Oral Anticoagulants: A Focused Review for Stroke Physicians  Journal Articles
• Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism  Journal Articles
• Novel oral anticoagulants in gastroenterology practice  Journal Articles
• Novel oral anticoagulants in secondary prevention of stroke  Journal Articles
• Oncostatin M induction of eotaxin-1 expression requires the convergence of PI3′K and ERK1/2 MAPK signal transduction pathways  Journal Articles
• Oral Anticoagulant Therapy  Journal Articles
• Oral Rivaroxaban for Symptomatic Venous Thromboembolism  Journal Articles
• Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism  Journal Articles
• Oral anticoagulant use in addition to antiplatelet therapy for secondary prevention in acute coronary syndrome: current perspectives  Journal Articles
• Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement  Journal Articles
• Oral, Direct Factor Xa Inhibitors in Development for the Prevention and Treatment of Thromboembolic Diseases  Journal Articles
• Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation  Journal Articles
• Overview of the New Oral Anticoagulants  Journal Articles
• Panax quinquefolium saponin combined with dual antiplatelet drugs inhibits platelet adhesion to injured HUVECs via PI3K/AKT and COX pathways  Journal Articles
• Perioperative management of patients who are receiving a novel oral anticoagulant  Journal Articles
• Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy  Journal Articles
• Pharmacologic Properties of the New Oral Anticoagulants: A Clinician-oriented Review with a Focus on Perioperative Management  Journal Articles
• Physiological evidence of a postsynaptic inhibition of the tail flick reflex by a cannabinoid receptor agonist  Journal Articles
• Pinaverium acts as L-type calcium channel blocker on smooth muscle of colon  Journal Articles
• Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban – an Oral, Direct Factor Xa Inhibitor – in Patients Undergoing Major Orthopaedic Surgery  Journal Articles
• Potent enantioselective inhibition of DNA-dependent protein kinase (DNA-PK) by atropisomeric chromenone derivatives  Journal Articles
• Potential of new anticoagulants in patients with cancer  Journal Articles
• Practical aspects of new oral anticoagulant use in atrial fibrillation  Journal Articles
• Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk  Journal Articles
• Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban  Journal Articles
• Procoagulants for management of bleeding with the new oral anticoagulants  Journal Articles
• Prokinetics for functional dyspepsia  Journal Articles
• Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery  Journal Articles
• Reduced-Intensity Rivaroxaban for the Prevention of Recurrent Venous Thromboembolism  Journal Articles
• Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban  Journal Articles
• Response to “Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban”  Journal Articles
• Response.  Journal Articles
• Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit)  Journal Articles
• Rivaroxaban for stroke prevention in atrial fibrillation: a critical review of the ROCKET AF trial  Journal Articles
• Rivaroxaban for the prevention and treatment of venous thromboembolism  Journal Articles
• Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty  Journal Articles
• Rivaroxaban for thromboprophylaxis after orthopaedic surgery: Pooled analysis of two studies  Journal Articles
• Rivaroxaban for treatment of HIT: A riveting first experience  Journal Articles
• Rivaroxaban in Orthopedic Surgery — A Change of Paradigm?  Journal Articles
• Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty  Journal Articles
• Rivaroxaban versus enoxaparin after total knee arthroplasty  Journal Articles
• Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial  Journal Articles
• Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study  Journal Articles
• Role of sphingolipids in the transport of prosaposin to the lysosomes  Journal Articles
• Selective factor Xa inhibition for thromboprophylaxis  Journal Articles
• Shear flow-induced motility ofDictyostelium discoideumcells on solid substrate  Journal Articles
• Suicidal Ideation and Behavior in Adolescents Aged 12–16 Years: A 17‐Year Follow‐Up  Journal Articles
• Superantigen immune stimulation activates epithelial STAT-1 and PI 3-K: PI 3-K regulation of permeability  Journal Articles
• The arotinoids: early clinical experience and discussion of future development.  Journal Articles
• The arotinoids: early clinical experience and discussion of future development.  Journal Articles
• The effects of rivaroxaban on the complications of surgery after total hip or knee replacement  Journal Articles
• The top 4 advances in antithrombotic care in the last year  Journal Articles
• Therapeutic Potential of Spleen Tyrosine Kinase Inhibition for Treating High-Risk Precursor B Cell Acute Lymphoblastic Leukemia  Journal Articles
• Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada  Journal Articles
• Transition from apixaban to warfarin—addressing excess stroke, systemic embolism, and major bleeding  Journal Articles
• Treatment of venous thromboembolism with dabigatran  Journal Articles
• USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway  Journal Articles
• Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study  Journal Articles
• Venous thromboembolism management: where do novel anticoagulants fit?  Journal Articles
• Well-managed warfarin is superior to NOACs Response  Journal Articles
• XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation  Journal Articles